Clarendon Private’s Boston Scientific BSX Stock Holding History

Clarendon Private’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,762	Closed	-$299K	–	126
2026 Q1	$299K	Sell	4,762 -1,451	-23%	-$116K	0.23%	96
2025 Q4	$592K	Sell	6,213 -1,002	-14%	-$98.2K	0.5%	57
2025 Q3	$704K	Sell	7,215 -2,831	-28%	-$293K	0.64%	45
2025 Q2	$1.08M	Buy	10,046 +1,037	+12%	+$105K	1.04%	23
2025 Q1	$909K	Buy	9,009 +1,142	+15%	+$115K	0.96%	30
2024 Q4	$703K	Buy	+7,867	New	+$693K	0.74%	36

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Clarendon Private's BSX Position: Q2 2026 in Review

Clarendon Private sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 4,762 shares — an estimated $299K sold.

Clarendon Private first reported a position in BSX in Q4 2024 and held it in 6 quarters. The position peaked at $1.08M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Clarendon Private reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Clarendon Private sold 4,762 Boston Scientific shares in Q2 2026, an estimated $299K.
Clarendon Private first reported a position in Boston Scientific in Q4 2024 and held it in 6 quarters.
Clarendon Private's Boston Scientific position peaked at $1.08M in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Clarendon Private's 13F filing for Q2 2026, filed 22 Jul 2026.